Clinical Outcomes of Migraine Patients Receiving Calcitonin Gene-Related Peptide Antagonists from an Integrated Health System Specialty Pharmacy
This poster evaluates the percent reduction in patient-reported monthly migraine days of patients receiving CGRPs from an integrated health system specialty pharmacy (HSSP).